Table 2.
Serum VEGFR-3 and CEA levels and survival in advanced gastric cancer patients
| Factors | n | MST (mo) (95% CI) | P1 |
| VEGFR-3 (ng/mL) | |||
| Low ≤ 70.6 | 52 | 15.400 (11.799-19.001) | < 0.001 |
| High > 70.6 | 29 | 7.700 (5.691-9.709) | |
| CEA (ng/mL) | |||
| Low ≤ 23.5 | 57 | 15.800 (11.223-20.377) | < 0.001 |
| High > 23.5 | 24 | 8.600 (7.219-9.981) |
1
Adjusted P-value based on log-rank statistics after 1000 bootstrap simulations. VEGFR-3: Vascular endothelial growth factor receptor-3; CEA: Carcinoembryonic antigen; CI: Confidence interval.